Predictors of mid-term functional outcomes for robot-assisted Madigan simple prostatectomy: results of a multicentric series according to the BPH-6 achievement.

Journal: Minerva urology and nephrology
PMID: 37728496

Abstract

BACKGROUND: BPH-6 achievement remains an objective far to be evaluated for every technique currently available for the surgical management of bladder outlet obstruction (BOO) with the goal of preserving ejaculatory function. The aim of this study was to evaluate predictors of BPH-6 achievement of urethral-sparing robot assisted simple prostatectomy (us-RASP) on a large series performed at two tertiary-care centers.

Authors

  • Umberto Anceschi
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy. Electronic address: umberto.anceschi@gmail.com.
  • Daniele Amparore
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Francesco Prata
    Department of Urology, Campus Bio-Medico University, Rome, Italy.
  • Francesco Tedesco
    Department of Urology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.
  • Loris Cacciatore
    Department of Urology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.
  • Enrico Checcucci
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Alfredo M Bove
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
  • Sabrina De Cillis
    Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.
  • Andrea Iannuzzi
    Department of Urology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.
  • Alberto Quarà
    Endolase lab, GRC20, Sorbonne Université and PIMM-Arts et Métiers Paris Tech, Paris, France.
  • Alberto Ragusa
    Department of Urology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.
  • Michele Ortenzi
    Division of Urology, Department of Oncology, School of Medicine, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy.
  • Rocco S Flammia
    Department of Urology, La Sapienza University, Rome, Italy.
  • Ashanti Zampa
    Department of Clinical Trials, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Leonardo Misuraca
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
  • Gabriele Tuderti
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
  • Aldo Brassetti
    Fondazione Vincenzo Pansadoro, Centro di Urologia Laparoscopica e Oncologia Medica, Rome, Italy. Electronic address: aldo.brassetti@gmail.com.
  • Mariaconsiglia Ferriero
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
  • Riccardo Mastroianni
    Complex Operative Unit of Urology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Antonio Tufano
    Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Cristian Fiori
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Francesco Porpiglia
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Michele Gallucci
    Department of Urology, La Sapienza University, Rome, Italy.
  • Giuseppe Simone
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.

Keywords

External Resources

Popular Topics
Recent Journals